Identification and validation of proteinase 3 and latent matrix-metalloproteinase 9 as potential biomarkers for chronic lung transplant rejection

Clinical Proteomics

Volumn 3, Issue 1-4, 2007, Pages 3-12

  Zhang, Yan ^a   Wendt, Christine H ^b   Hertz, Marshall I ^b   Nelsestuen, Gary L ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Bioinformatics; Biomarker discovery; Biomarker validation; Bronchoalveolar lavage fluid (BALF); Chronic rejection; Lung transplant; Mass spectrometry; Proteomics

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; IMMUNOGLOBULIN M; MYELOBLASTIN;

ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG GRAFT REJECTION; LUNG LAVAGE; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 51749089535     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12014-007-0001-6     Document Type: Article

References (34)

1. EP Trulock LB Edwards DO Taylor MM Boucek BM Keck MI Hertz 2005 Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005 J Heart Lung Transplant 24 8 956 967
2. CM Burke J Theodore KD Dawkins SA Yousem N Blank ME Billingham 1984 Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation Chest 86 6 824 829
3. M Estenne MI Hertz 2002 Bronchiolitis obliterans after human lung transplantation Am J Respir Crit Care Med 166 4 440 444
4. JD Cooper M Billingham T Egan MI Hertz T Higenbottam J Lynch 1993 A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation J Heart Lung Transplant 12 5 713 716
5. M Estenne JR Maurer A Boehler JJ Egan A Frost M Hertz 2002 Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 3 297 310
6. B DiGiovine JP Lynch III FJ Martinez A Flint RI Whyte MD Iannettoni 1996 Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8 J Immunol 157 9 4194 4202
7. GC Riise BA Andersson C Kjellstrom G Martensson FN Nilsson W Ryd 1999 Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant Eur Respir J 14 5 1123 1130
8. J Scholma DJ Slebos HM Boezen JWK van den Berg W van der Bij WJ de Boer 2000 Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation Am J Respir Crit Care Med 162 6 2221 2225
9. KC Meyer DR Nunley JH Dauber KC Meyer DR Nunley JH Dauber 2001 Neutrophils, unopposed neutrophil elastase, and alpha 1-antiprotease defenses following human lung transplantation Am J Respir Crit Care Med 164 1 97 102
10. JA De Andrade JP Crow L Viera C Bruce Alexander K Randall Young DC McGiffin 2000 Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts Am J Respir Crit Care Med 161 6 2035 2042
11. MI Hertz CA Henke RE Nakhleh KR Harmon WA Marinelli JMK Fox 1992 Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor Proc Natl Acad Sci USA 89 21 10385 10389
12. SA Yousem GJ Berry PT Cagle D Chamberlain AN Husain RH Hruban 1996 Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group J Heart Lung Transplant 15 1 Pt 1 1 15
13. IP Neuringer W Chalermskulrat R Aris 2005 Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review J Heart Lung Transplant 24 1 3 19
14. R Wattiez P Falmagne 2005 Proteomics of bronchoalveolar lavage fluid Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 815 1-2 169 178
15. GL Nelsestuen Y Zhang MB Martinez NS Key B Jilma M Verneris 2005 Plasma protein profiling: unique and stable features of individuals Proteomics 5 15 4012 4024
16. Y Zhang M Wroblewski MI Hertz CH Wendt TM Cervenka GL Nelsestuen 2006 Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid Proteomics 6 3 1001 1010
17. GL Nelsestuen MB Martinez MI Hertz K Savik CH Wendt 2005 Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection Proteomics 5 6 1705 1713
18. J Wu M Kobayashi EA Sousa W Liu J Cai SJ Goldman 2005 Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge Mol Cell Proteomics 4 9 1251 1264
19. F Buhling A Ittenson D Kaiser G Thölert B Hoffmann D Reinhold 2000 MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia Immunol Lett 71 3 185 190
20. S Benhamou WJ Lee AK Alexandrie P Boffetta C Bouchardy D Butkiewicz 2002 Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk Carcinogenesis 23 8 1343 1350
21. TA Merritt CG Cochrane K Holcomb B Bohl M Hallman D Strayer 1983 Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia J Clin Invest 72 2 656 666
22. NV Rao GV Rao BC Marshall JR Hoidal 1996 Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G J Biol Chem 271 6 2972 2978
23. N Borregaard JB Cowland 1997 Granules of the human neutrophilic polymorphonuclear leukocyte Blood 89 10 3503 3521
24. CA Owen EJ Campbell 1999 The cell biology of leukocyte-mediated proteolysis J Leukoc Biol 65 2 137 150
25. J Just C Moog-Lutz A Houzel-Charavel S Canteloup A Grimfeld V Witko-Sarsat 1999 Proteinase 3 mRNA expression is induced in monocytes but not in neutrophils of patients with cystic fibrosis FEBS Lett 457 3 437 440
26. EC Hagen BE Ballieux LA van Es MR Daha FJ van der Woude 1993 Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences Blood 81 8 1996 2002
27. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 3 161 174
28. SK Katiyar 2006 Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins Endocr Metab Immune Disord Drug Targets 6 1 17 24
29. EJ Armstrong DA Morrow MS Sabatine 2006 Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation Circulation 113 9 e382 e385
30. M Rouis 2005 Matrix metalloproteinases: a potential therapeutic target in atherosclerosis Curr Drug Targets Cardiovasc Haematol Disord 5 6 541 548
31. MM Gueders JM Foidart A Noel DD Cataldo 2006 Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases Eur J Pharmacol 533 1-3 133 144
32. B Dubois S Masure U Hurtenbach L Paemen H Heremans J van den Oord 1999 Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions J Clin Invest 104 11 1507 1515
33. C Creighton S Hanash 2003 Expression of matrix metalloproteinase 9 (MMP-9/gelatinase B) in adenocarcinomas strongly correlated with expression of immune response genes In Silico Biol 3 3 301 311
34. S Matecki G Py K Lambert C Peyreigne J Mercier C Prefaut 2002 Effect of prolonged undernutrition on rat diaphragm mitochondrial respiration Am J Respir Cell Mol Biol 26 2 239 245